Dermatitis, atopic
Clinical trials for Dermatitis, atopic explained in plain language.
Never miss a new study
Get alerted when new Dermatitis, atopic trials appear
Sign up with your email to follow new studies for Dermatitis, atopic, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a new injection calm severe eczema in kids?
Disease control Not yet recruitingThis trial is testing an experimental drug called 611 in children aged 2 to 12 with moderate-to-severe atopic dermatitis, a common skin condition that causes itchy, inflamed skin. The drug is designed to block a specific immune signal that drives the inflammation behind eczema. T…
Matched conditions: DERMATITIS, ATOPIC
Phase 3 • Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New shot could soothe severe eczema in teens
Disease control Not yet recruitingThis study tests a new drug called MG-K10 in 180 teens aged 12-17 with moderate-to-severe eczema that hasn't responded well to creams. The drug is given as a shot every two weeks for a year. Researchers will check if it clears skin and reduces itching better than a placebo.
Matched conditions: DERMATITIS, ATOPIC
Phase 3 • Sponsor: Shanghai Mabgeek Biotech.Co.Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
Eczema ointment showdown: which works better?
Symptom relief Not yet recruitingThis study compares two prescription ointments, crisaborole and tacrolimus, for treating mild to moderate eczema (atopic dermatitis) in people aged 5 to 25. Researchers will measure how much the skin improves after treatment with each ointment. The goal is to find out which one w…
Matched conditions: DERMATITIS, ATOPIC
Phase 4 • Sponsor: Cairo University • Aim: Symptom relief
Last updated Jun 27, 2026 08:14 UTC